# Mitoconix Bio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/mitoconix-bio

- Industry: Biotechnology
- Headquarters: Israel
- Total disclosed funding: $20M
- Latest round: Series A (Jun 27, 2017)
- Investors on record: 5

## About

Founded in 2016 and based in Ness Ziona, Israel, Mitoconix Bio Ltd. operates as a biopharmaceutical company that develops mitochondrial health as a disease-modifying therapeutic for neurodegenerative diseases.

## Funding rounds

- Series A, Jun 27, 2017, $20M — OrbiMed Advisors, SV Health Investors, Remiges Ventures, Arix Bioscience, RM Global Partners

## Investors

- OrbiMed Advisors (https://capitalatlas.ai/funds/orbimed-advisors) — Series A
- SV Health Investors (https://capitalatlas.ai/funds/sv-health-investors) — Series A
- Remiges Ventures (https://capitalatlas.ai/funds/remiges-ventures) — Series A
- Arix Bioscience (https://capitalatlas.ai/funds/arix-bioscience) — Series A
- RM Global Partners (https://capitalatlas.ai/funds/rm-global-partners) — Series A